The Central government has significantly expanded the testing functions of the Central Drugs Laboratory (CDL) located at the Chaudhary Charan Singh–National Institute of Animal Health (CCS-NIAH) in Baghpat, Uttar Pradesh, to encompass a wider range of veterinary vaccines.
Information was available with The Chenab Times that prior to this amendment, the CCS-NIAH was authorized to test only two types of veterinary vaccines. The recent notification substantially broadens this scope, empowering the institute to test 42 distinct veterinary vaccines.
These vaccines are crucial for the prevention and control of a variety of animal diseases, including Canine Distemper, Canine Coronavirus, Duck Plague, Fowl Pox, Salmonella, and Tetanus. The expanded testing capabilities will now cover vaccines for a range of animals such as dogs, horses, poultry, and other livestock, bolstering the nation’s capacity to safeguard animal health.
This enhancement in testing capacity at CCS-NIAH is anticipated to streamline the import processes and regulatory approvals for veterinary biologicals. It is also expected to fortify the national quality assurance framework for veterinary vaccines, ultimately leading to reduced testing timelines and improved turnaround times for manufacturers operating within the sector.
The Union Ministry of Health, in a statement, highlighted India’s prominent position as a global producer of veterinary vaccines. The expansion of testing facilities at CCS-NIAH is seen as a strategic move to support the continued growth of the veterinary vaccine industry. It aims to ensure the timely availability of high-quality, assured vaccines, thereby contributing to the overall health and productivity of the nation’s animal population.
The broadened mandate of the Central Drugs Laboratory at CCS-NIAH is a crucial step towards modernizing and strengthening the infrastructure for animal healthcare in India. By enabling the testing of a more comprehensive list of veterinary vaccines, the government aims to ensure that animal health products meet stringent quality standards before they are deployed across the country.
The initiative is aligned with the broader national objective of promoting animal husbandry and ensuring food security through healthy livestock. The increased testing capacity is expected to reduce reliance on external testing facilities, fostering self-sufficiency and enhancing the competitiveness of Indian veterinary vaccine manufacturers in both domestic and international markets.
Industry stakeholders have welcomed the move, noting that faster regulatory clearances and improved quality control will be beneficial for disease prevention and control programs. This expansion is expected to play a vital role in preventing the outbreak and spread of zoonotic diseases, further contributing to public health and economic stability.
The CCS-NIAH, situated in Uttar Pradesh, will now serve as a more comprehensive hub for the quality assessment of veterinary vaccines. This development is expected to have a ripple effect across the agricultural and animal husbandry sectors, supporting farmers and livestock owners by ensuring access to safe and effective vaccines for their animals. The institute’s enhanced capabilities will be instrumental in maintaining the health of animals crucial for both agricultural output and companionship.
The Ministry of Health’s statement emphasized that this expansion is a testament to the government’s commitment to enhancing animal health infrastructure. The focus is on ensuring that India not only remains a leading producer but also a benchmark for quality in the global veterinary vaccine market. The enhanced testing capabilities will support research and development efforts, encouraging innovation in vaccine technology and formulation.
By increasing the number of vaccines tested at CCS-NIAH, the government aims to create a more robust ecosystem for veterinary medicine. This includes improving surveillance mechanisms for animal diseases and ensuring that rapid diagnostic and preventive tools are readily available. The move is part of a larger strategy to modernize the animal health sector and align it with international standards of quality and safety.
The expansion of the Central Drugs Laboratory’s functions at CCS-NIAH signifies a forward-looking approach to animal healthcare, recognizing the integral role of healthy livestock in India’s economy and food security. The extended testing mandate is poised to strengthen the nation’s biosecurity measures and enhance its preparedness for emerging animal health challenges.
❤️ Support Independent Journalism
Your contribution keeps our reporting free, fearless, and accessible to everyone.
Or make a one-time donation
Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle
(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)
The Chenab Times News Desk
